- Leadership status in the domestic & global Injectable business.
- Strong growth opportunity is driven by AmeriGen’s entry into semi-regulated & regulated markets which are supported by its strong DMF and ANDA pipeline.
- WHO-GMP/ PICs compliance Injectables (Bags & PFS/Vials) manufacturing facilities worth of $ 4.5Mn.
- Increased focus on research programme including ANDA, NDDS and NCE providing multiple drivers of growth going forward.
- Tie-ups with global players.